Ciclesonide
Products in Health Canada’s databases that list Ciclesonide as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 7
- 4 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 18
- Products in all
- 7
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| ALVESCO (100 MCG) | 02285606 | Marketed | Covis Pharma Gmbh | |
| ALVESCO (200 MCG) | 02285614 | Marketed | Covis Pharma Gmbh | |
| OMNARIS (50 MCG) | 02303671 | Marketed | Covis Pharma Gmbh | |
| APO-CICLESONIDE (50 MCG) | 02417316 | Dormant | Apotex Inc. | |
| ALVESCO (50 MCG) | 02285592 | Cancelled Pre Market | Takeda Canada Incorporated | |
| ASERVO EQUIHALER (343 MCG) | 02498634 | Cancelled Post Market | Boehringer Ingelheim Animal Health Canada Inc. | |
| OMNARIS HFA (50 MCG) | 02404311 | Cancelled Post Market | Takeda Canada Incorporated |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- ALVESCOMarch 31, 2021 · NOC 25587
- OMNARISFebruary 17, 2021 · NOC 25242
- ASERVO EQUIHALERJanuary 7, 2021 · NOC 24958
- ALVESCOOctober 2, 2020 · NOC 24385
- ASERVO EQUIHALERApril 30, 2020 · NOC 23533
- ALVESCOJanuary 20, 2017 · NOC 18893
- OMNARISJanuary 20, 2017 · NOC 18894
- APO-CICLESONIDEMay 1, 2015 · NOC 16859
- OMNARIS HFAFebruary 14, 2014 · NOC 15268
- DRYMIRAOctober 4, 2013 · NOC 14779
- OMNARIS HFAMarch 28, 2013 · NOC 14262
- OMNARISJanuary 10, 2013 · NOC 14013
- ALVESCOJune 27, 2012 · NOC 13440
- ALVESCOJanuary 15, 2009 · NOC 9996
- OMNARISDecember 10, 2007 · NOC 9235
- ALVESCOAugust 14, 2007 · NOC 8974
- ALVESCOJuly 20, 2007 · NOC 8923
- ALVESCOSeptember 11, 2006 · NOC 8254